Back
Rhythm Pharmaceuticals Vs. Insmed Industry Stock Comparison
Buy
66
RYTM
Rhythm Pharmaceuticals
Last Price:
36.74
Seasonality Move:
106.43%
Sell
30
INSM
Insmed
Last Price:
21.97
Seasonality Move:
-9.01%
Buy
66
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $36.76. The Score for RYTM is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Insmed (INSM)
is a Sell
Is Insmed a Buy, Sell or Hold?
- The current Insmed [INSM] share price is $22.00. The Score for INSM is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- INSM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $36.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.77 | Sell |
| Relative Strength Index (14 RSI): | 38.89 | Sell |
| Chaikin Money Flow: | -296024 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.77 - 41.11) | Sell |
| Bollinger Bands (100): | (38.76 - 45.58) | Sell |
INSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.68 | Sell |
| Relative Strength Index (14 RSI): | 27.18 | Sell |
| Chaikin Money Flow: | -2239739 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.19 - 26.03) | Sell |
| Bollinger Bands (100): | (25.55 - 28.63) | Sell |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.21 | Sell |
| 20-day SMA: | 39.54 | Sell |
| 50-day SMA: | 39.96 | Sell |
| 200-day SMA: | 35.77 | Buy |
| 8-day EMA: | 38.06 | Sell |
| 20-day EMA: | 38.97 | Sell |
| 50-day EMA: | 40.02 | Sell |
| 200-day EMA: | 36.21 | Buy |
INSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.33 | Sell |
| 20-day SMA: | 25.14 | Sell |
| 50-day SMA: | 25.96 | Sell |
| 200-day SMA: | 26.23 | Sell |
| 8-day EMA: | 24.06 | Sell |
| 20-day EMA: | 24.9 | Sell |
| 50-day EMA: | 25.8 | Sell |
| 200-day EMA: | 25.63 | Sell |
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.28 per share, a decrease this year of $1.36 per share, and an increase next year of $2.03 per share.
Insmed Earnings Growth & INSM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.80 per share, and an increase next year of $1.04 per share.
Rhythm Pharmaceuticals Technical Analysis
| May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Insmed Technical Analysis
| May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||